Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Clinical Outcomes Between Acute Coronary Syndrome (ACS) and Stable Angina

被引：0
|
作者：
Hokimoto, Seiji [1 ]
Akasaka, Tomonori [1 ]
Kaikita, Koichi [1 ]
Nakagawa, Kazuko [2 ]
Ogawa, Hisao [1 ]
机构：
[1] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan
[2] Kumamoto Univ, Div Pharmacol & Therapeut, Kumamoto, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Acute coronary syndromes; Pharmacogenetics; Percutaneous coronary intervention; Genetics;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16546
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Is There Difference Impact of CYP2C19 Polymorphism on Platelet Reactivity and Adverse Clinical Events Between Acute Coronary Syndrome (ACS) and Stable Angina
    Hokimoto, Seiji
    Mizobe, Michio
    Nagano, Masahide
    Kaikita, Koici
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2012, 126 (21)
  • [2] Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina
    Arima, Yuichiro
    Hokimoto, Seiji
    Akasaka, Tomonori
    Mizobe, Koichi
    Kaikita, Koichi
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2015, 65 (5-6) : 494 - 500
  • [3] Impact of CYP2C19 Polymorphism and Diabetes Mellitus on Platelet Reactivity and Clinical Outcomes in Patients Following Coronary Stent Placement
    Hokimoto, Seiji
    Mizobe, Michio
    Chitose, Tadasuke
    Kaikita, Koichi
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2011, 124 (21)
  • [4] Is There Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Cardiovascular Events Between Chronic Kidney Disease (CKD) and Non-CKD ?
    Hokimoto, Seiji
    Akasaka, Tomonori
    Arima, Yuichiro
    Kaikita, Koichi
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [5] Do Use of Proton Pump Inhibitor (PPI) and CYP2C19 Polymorphism Have the Same Degree of Impact on Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) ?
    Hokimoto, Seiji
    Yamamoto, Koichiro
    Chitose, Tadasuke
    Ono, Takamichi
    Kaikita, Koichi
    Tsuijita, Kenichi
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2010, 122 (21)
  • [6] Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation
    Hokimoto, Seiji
    Mizobe, Michio
    Akasaka, Tomonori
    Arima, Yuichiro
    Kaikita, Koichi
    Nakagawa, Kazuko
    Ogawa, Hisao
    THROMBOSIS RESEARCH, 2014, 133 (04) : 599 - 605
  • [7] Relevance of CYP2C19*2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel
    Cano, Pedro
    Consuegra-Sanchez, Luciano
    Conesa, Pablo
    Torres-Moreno, Daniel
    Jaulent, Leticia
    Dau, Derek
    Pico, Francisco
    Villegas, Manuel
    MEDICINA CLINICA, 2014, 143 (01): : 6 - 12
  • [8] Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy
    Yamamoto, Koichiro
    Hokimoto, Seiji
    Chitose, Tadasuke
    Morita, Kazunori
    Ono, Takamichi
    Kaikita, Koichi
    Tsujita, Kenichi
    Abe, Tomohide
    Deguchi, Mariko
    Miyagawa, Haruna
    Saruwatari, Junji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2011, 57 (02) : 194 - 201
  • [9] The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry
    Azzahhafi, Jaouad
    van den Broek, Wout W. A.
    Yin, Dean R. P. P. Chan Pin
    Harmsze, Ankie M.
    van Schaik, Ron H. N.
    ten Berg, Jurrien M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 28
  • [10] Gender Differences in Impact of CYP2C19 Polymorphism on Risk of Coronary Artery Disease
    Hokimoto, Seiji
    Akasaka, Tomonori
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
12345